Literature DB >> 10961589

Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells.

S Kawachi1, Z Morise, S R Jennings, E Conner, A Cockrell, F S Laroux, R P Chervenak, M Wolcott, H van der Heyde, L Gray, L Feng, D N Granger, R A Specian, M B Grisham.   

Abstract

The objectives of this study were to quantify colonic cytokine and endothelial cell adhesion molecule (ECAM) expression in the colons of severe combined immunodeficient (SCID) mice reconstituted with different subsets of CD4+ T lymphocytes. We found that animals injected with CD45RBhigh but not CD45RBlow T cells or phosphate-buffered saline (PBS) developed clinical evidence of colitis at 6-8 weeks following reconstitution, as assessed by loss of body weight, development of loose stools and/or diarrhea, and histopathology. Concurrent with the onset of distal bowel inflammation was enhanced expression of a variety of Th1 and macrophage-derived cytokines including interferon gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-12, and IL-18 lymphotoxin-beta. In addition, message levels and vascular surface expression of ICAM-1, VCAM-1, and MAdCAM-1 were all significantly enhanced in the colitic SCID mice reconstituted with CD45RBhigh T cells compared with SCID mice reconstituted with PBS or CD45RBlow T cells that did not develop disease. Significant increases in some of these ECAMs were also noted in the cecum and stomach and to a lesser degree in the small bowel. Our data confirm that reconstitution of SCID mice with CD45RBhigh but not CD45RBlow T cells induces chronic colitis, and that the colonic inflammation is associated with enhanced expression of proinflammatory cytokines and different ECAMs in the colon. Furthermore, our studies demonstrate that reconstitution of SCID mice with CD45RBhigh T cells enhances ECAM expression in tissues distant from the site of active inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961589     DOI: 10.1097/00054725-200008000-00003

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

Review 1.  Leukocyte adhesion molecules in animal models of inflammatory bowel disease.

Authors:  Jesús Rivera-Nieves; Gezahegn Gorfu; Klaus Ley
Journal:  Inflamm Bowel Dis       Date:  2008-12       Impact factor: 5.325

Review 2.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

3.  T cell-associated α4β7 but not α4β1 integrin is required for the induction and perpetuation of chronic colitis.

Authors:  E Kurmaeva; J D Lord; S Zhang; J R Bao; C G Kevil; M B Grisham; D V Ostanin
Journal:  Mucosal Immunol       Date:  2014-04-09       Impact factor: 7.313

4.  Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases.

Authors:  Eduardo J Villablanca; Barbara Cassani; Ulrich H von Andrian; J Rodrigo Mora
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

5.  Altered microvascular hemodynamics during the induction and perpetuation of chronic gut inflammation.

Authors:  Norman R Harris; Joseph R Whatley; Patsy R Carter; Georgia A Morgan; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02-12       Impact factor: 4.052

Review 6.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

Authors:  Dmitry V Ostanin; Jianxiong Bao; Iurii Koboziev; Laura Gray; Sherry A Robinson-Jackson; Melissa Kosloski-Davidson; V Hugh Price; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

7.  Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha.

Authors:  Makoto Sasaki; Paul Jordan; Tomas Welbourne; Alireza Minagar; Takashi Joh; Makoto Itoh; John W Elrod; J Steven Alexander
Journal:  BMC Physiol       Date:  2005-02-06

8.  Development of Mucosal PNAd+ and MAdCAM-1+ Venules during Disease Course in Ulcerative Colitis.

Authors:  Britt Roosenboom; Ellen G van Lochem; Jos Meijer; Carolijn Smids; Stefan Nierkens; Eelco C Brand; Liselot W van Erp; Larissa G J M Kemperman; Marcel J M Groenen; Carmen S Horjus Talabur Horje; Peter J Wahab
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.